Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHronic Use of Amiodarone aGAinSt Implantable Cardioverter-defibrillator Therapy for Primary Prevention of Death in Patients With Chagas Cardiomyopathy Study (CHAGASICS)

NCT01722942 is registered in ClinicalTrials.gov with InCor Heart Institute as lead sponsor.

NCT NCT01722942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01722942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHronic Use of Amiodarone aGAinSt Implantable Cardioverter-defibrillator Therapy for Primary Prevention of Death in Patients With Chagas Cardiomyopathy Study (CHAGASICS)
Lead sponsor
InCor Heart Institute
Phase
Not applicable
Overall status
Unknown status
Start date
October 6, 2014
Completion date
July 31, 2022
Enrollment
1,100 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

at least 10 points in rassi risk score for death, chagas cardiomyopathy, non-sustained ventricular tachycardia